| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0002 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |